During every round of eukaryotic cell division, a small amount of DNA is lost from the ends of each chromosome (Olovnikov, 1973; Watson, 1972). Termed the end replication problem, this phenomenon is countered by two complementary adaptations. First, repetitive noncoding DNA sequences, known as telomeres, are found at chromosomal ends, preventing the loss of vital genetic information during each cell division (Blackburn and Gall, 1978; Moyzis et al., 1988). Second, the ribonucleoprotein telomerase elongates shortened telomeres at chromosomal ends using a reverse transcriptase activity (Greider and Blackburn, 1987). Without elongation, telomeres will eventually reach a critically short length, causing cells to undergo apoptosis or become senescent (Hayflick and Moorhead, 1961; Meyerson, 1998). Because telomerase plays such a fundamental role in the temporal regulation of cell division, aberrations in telomerase are implicated in numerous human diseases. These include premature aging, idiopathic pulmonary fibrosis (IPF), dyskeratosis congenita, and cancer (Blasco, 2005; Kim et al., 1994; Nelson and Bertuch, 2012). In particular,~90% of cancers upregulate telomerase to combat telomere shortening and enable unlimited cell division, as opposed to somatic cells where telomerase is absent (Jafri et al., 2016).

The implication of telomerase in multiple human diseases underscores the importance of understanding its catalytic cycle at the molecular level. Although the human telomerase holoenzyme is composed of multiple accessory subunits, catalysis is localized to the telomerase reverse transcriptase (TERT) subunit (Nguyen et al., 2018). Historically, biochemical characterization of human TERT (hTERT) has proven challenging, in part because of technical difficulties purifying and reconstituting large quantities of active telomerase (Ramakrishnan et al., 1997; Schmidt et al., 2016). As a result, many fundamental parameters describing the telomerase catalytic cycle have remained undefined. These enzymatic constants are essential for understanding the roles of active site residues, the selection of right from the wrong nucleotides (fidelity), and the prevention of ribonucleotide triphosphate (rNTP) insertion (sugar discrimination). The faithful extension of telomeres by telomerase is critical because aberrations in telomeric sequences prevent shelterin proteins from capping telomeres, thus promoting genomic instability (de Lange, 2005; Nandakumar et al., 2010). Structural studies of human telomerase have also been historically challenging. Currently, the highest resolution structural snapshot of human telomerase is a cryo-EM structure at 8 Å resolution (Nguyen et al., 2018). This structure represents a milestone in telomerase structural biology, revealing details of the telomerase tertiary and secondary structure. However, the positions of amino acids are difficult to distinguish at this resolution, leaving many molecular details of the catalytic cycle ambiguous.

To mitigate the difficulties inherent in the biochemical characterization of human telomerase, several model systems have been established. These include models from yeast, the protazoa Tetrahymena thermophila (with which a 5 Å cryo-EM structure was recently determined), and the insect model Tribolium castaneum (sequence alignment shown in Figure 1—figure supplement 1; Gillis et al., 2008; Jiang et al., 2018; Petrova et al., 2018). For biochemical characterization of TERT, we opted to use T. castaneum TERT (tcTERT) for the following reasons: first, tcTERT readily fit into the cryo-EM density of hTERT and aligns well with the recent cryo-EM structure from T. thermophila, highlighting the conserved secondary structure (Figure 1—figure supplement 2); second, upon alignment with hTERT, the active site pocket of tcTERT exhibits a high degree of sequence identity (Supplementary file 1, Table 1a); third, using a truncated version of the T. castaneum telomerase RNA component (TR), we can readily obtain sufficient quantities of isolated, active tcTERT for characterization of the telomerase catalytic cycle by pre-steady-state kinetics and X-ray crystallography (Gillis et al., 2008; Nguyen et al., 2018). Although TERTs have highly conserved active sites, there are significant changes in the domain architecture between human and tcTERT. These include tcTERT lacking the N-terminal (TEN) domain and missing a portion of the insertion in fingers domain (IFD) (Supplementary file 1, Table 1b). These domains are essential for the activity of other telomerase homologs, and have been hypothesized to be particularly important for telomerase ratcheting during translocation (Steczkiewicz et al., 2011). Therefore, we kept our tcTERT kinetics within a single turnover (i.e. insertion) regime, and, wherever possible, complemented the kinetic results with human telomerase studies to characterize the catalytic cycle of telomerase. Using this combined approach, we have elucidated the role of conserved telomerase active site residues and determined the mechanisms of fidelity and rNTP discrimination.

The TERT subunit of telomerase elongates telomeric DNA using a conserved catalytic cycle as outlined in Figure 1A, Figure 1—figure supplement 3, and here. First, telomerase anneals its RNA template to the end of telomeric DNA to form a binary complex (TERT:DNA, Figure 1A, state A₁). Next, the binary complex binds an incoming dNTP and samples for proper Watson-Crick base pairing to the RNA template (Figure 1A, state B₁). The transition between these two states represents the nucleotide binding step, measured as a dissociation constant (K_d). If the resulting ternary complex (TERT:DNA:dNTP) is in the proper orientation, TERT will catalyze the formation of a phosphodiester bond and extend the telomere by one nucleotide (Figure 1A, state C₁). The transition between these two states is the chemistry step, and its theoretical maximum rate with saturating nucleotide concentration is described as k_pol. Following insertion of the incoming nucleotide, telomerase will shift registry to align the active site with the next templating base (forming state A₂). This core catalytic cycle repeats six times, until a new telomeric repeat is added (Figure 1A, state C₆). All 18 telomerase states that are required to add one telomeric repeat are shown in Figure 1—figure supplement 3 for reference. Importantly, as the telomerase approaches the end of its template, the DNA:RNA duplex at the 5’ end begins to melt, enabling telomerase to either (1) translocate and anneal the RNA component to the newly extended telomeric repeat, thus allowing for additional repeat addition; or (2) dissociate from the telomeric DNA. The number of times that a single telomerase enzyme traverses this catalytic cycle is tightly regulated. It was recently shown telomerase becomes inactive after two repeats, but can be reactivated by the recently discovered intracellular telomerase-activating factors (iTAFs) (Sayed et al., 2019).

Figure 1 with 3 supplements see all

Download asset Open asset

Nucleotide bound ternary complex

We also determined the structure of TERT after binding an incoming nucleotide, but prior to catalysis (Figure 1A, state B₆). To capture the ternary complex, we utilized a non-hydrolyzable nucleotide analog 2'-deoxyguanosine-5'-[(α,β)-methyleno]triphosphate (dGpCpp). dGpCpp is identical to dGTP, except the bridging oxygen between the α and β phosphate is a carbon atom, which prevents catalysis (Batra et al., 2006; Gleghorn et al., 2011). Crystals of this complex grew in the same P3₂21 space group and diffracted to 2.9 Å resolution (Supplementary file 2, Table 2a). Comparing this ternary complex to the binary state (RMSD value of 1.52 Å, Figure 2A) indicates minimal structural rearrangements are required for TERT to bind dGpCpp. The active site residues that compose the nucleotide binding pocket of the pre-nucleotide binary complex coordinate the incoming dGpCpp, positioning its Watson-Crick face to hydrogen bond with the templating rC (Figure 2B,C). Two Mg⁺² ions exhibit octahedral coordination to facilitate nucleotide binding. The catalytic metal coordinates residues D251, D343, D344, the 3’-OH of the primer terminus, and the non-bridging oxygen of the dGpCpp α-phosphate (Figure 2D). The nucleotide metal coordinates the side chains of D251 and D343, the backbone carbonyl of I252, and a non-bridging oxygen on the α,β, and γ phosphates of the incoming dGpCpp (Figure 2D). Nucleoside binding residue R194 remains in a similar position to where it was in the prenucleotide state, but now forms a network of contacts between residue Q308 and the α phosphate of the incoming nucleotide, stabilizing it in an orientation near other nucleoside binding residues. Y256 is positioned near the C2 position of the deoxyribose sugar portion of the nucleoside, and Q308 coordinates the nucleoside component of the dGpCpp (Figure 2E). As a whole, the nucleoside binding residues encircle the nucleoside component of the incoming nucleotide, and position it so that the nucleobase can base stack with the primer terminus. Overall, this ternary complex provides insight into nucleotide selection by TERT and the specific roles of active site residues during nucleotide binding.

Figure 2

Download asset Open asset

Fidelity and sugar selectivity of TERT

Characterization of the telomerase catalytic mechanism was performed using pre-steady-state kinetics of single nucleotide insertion by tcTERT (Figure 3, Figure 3—figure supplement 1, Figure 3—figure supplement 2, and Supplementary file 3). These experiments determined both the K_d of the incoming nucleotide and the k_pol for nucleotide insertion by tcTERT, which have thus far proven unattainable for human telomerase (or any other homolog). TERT inserts the correctly matched dGTP across from a templating rC with a k_pol of 1.05 s⁻¹ and a K_d for the incoming dGTP of 18.1 μM (Figure 3A,D). Both of these values are comparable to other non-replicative DNA polymerases and the TERT K_M values obtained by steady-state kinetics (Brown et al., 2010; Chen et al., 2018). We further probed the role of tcTERT active site residues R194 and Q308 because their role during catalysis is not clear from the structures alone and both residues protrude into the nucleotide binding pocket (Figure 1F and Supplementary file 1, Table 1a). For TERT R194A, the k_pol decreased by 28-fold to 0.0369 s⁻¹, and the K_d for dGTP increased ~5 fold to 93 μM (Figure 3—figure supplement 2A,C). With the Q308A variant, the k_pol decreased ~60 fold to 0.30 s⁻¹ and the K_d for dGTP increased ~2 fold to 45 μM (Figure 3—figure supplement 2B,D). Therefore, R194 and Q308 primarily play a role in the chemistry step rather than the nucleotide binding. As the hTERT homolog to R194 (R631, Supplementary file 1, Table 1a) is implicated in IPF, we infer that mutations at R631 likely reduce hTERT’s k_pol, contributing to IPF pathologies (Basel-Vanagaite et al., 2008; Diaz de Leon et al., 2010).

Figure 3 with 2 supplements see all

Download asset Open asset

During telomeric extension, telomerase must select between a variety of nucleic acid substrates in order to properly maintain telomeric integrity. To probe the fidelity of telomerase, we applied pre-steady-state kinetics, assessing the efficiency with which TERT inserts nucleotides during telomeric elongation. Two separate types of nucleotide selection were examined: (1) the selection of a matched dGTP over a mismatched dATP, and (2) the selection of a matched deoxyribonucletide triphosphate (dNTP) over a matched rNTP (Figure 3B and C, Supplementary file 3, Table 3a and b). We observed that for the insertion of dATP opposite a templating rC, the catalytic efficiency starkly decreased compared to dGTP insertion, both at the nucleotide binding and chemistry step. For the mismatched insertion, the k_pol decreased 129-fold to 0.0081 s⁻¹ and the K_d increased 76-fold to 1.3 mM (Figure 3E). The resulting catalytic efficiencies (k_pol/K_d) for a matched versus mismatched nucleotide insertion indicate telomerase will insert the wrong nucleotide ~1 in 10,000 nucleotide insertion events. This places telomerase at a moderate fidelity of base selection compared to other DNA polymerases (Figure 3G). For rNTP discrimination, the k_pol for inserting a rGTP decreased 281-fold to 0.0037 s⁻¹ and the K_d increased 49-fold to 0.89 mM (Figure 3F). This results in a nearly 14,000-fold decrease in the catalytic efficiency for the insertion of a rNTP compared to a dNTP (i.e. sugar discrimination, Figure 3H). Because the cellular concentrations of rNTPs are around 50-fold higher on average than dNTPs, this sugar discrimination indicates telomerase will insert a rNTP ~1 in 280 insertion events in a cellular context (see discussion) (Traut, 1994).

The steric gate of telomerase

The high cellular concentration of rNTPs has resulted in most DNA polymerases evolving a structurally conserved active site residue which provides sugar discrimination by reducing the rate of rNTP insertion (Brown and Suo, 2011; Cavanaugh et al., 2010; Nick McElhinny et al., 2010). These residues are termed ‘steric gates’ because they clash with the 2’-OH of the incoming rNTP. Throughout the TERT catalytic cycle, we observed that Y256 rests in the minor groove of the DNA and is in position to clash with the 2’-OH of an incoming rNTP (Figure 2E). Therefore, we hypothesized this residue to be the steric gate in telomerase. To test this hypothesis, we performed pre-steady-state kinetics of rNTP insertion with the Y256A variant of TERT (Figure 4A,B). Compared to WT TERT, the insertion of a matched rGTP by Y256A showed a 1,490-fold increase in k_pol to 5.5 s⁻¹ and a 12-fold decrease in K_d to 73 μM (Figure 4C). The results for TERT Y256A inserting a matched dGTP were similar to that of the rGTP, with a k_pol and K_d of 6.6 s⁻¹ and 74 μM, respectively (Figure 4D). Thus, the sugar selectivity of TERT dropped from 14,000-fold between rGTP and dGTP for WT TERT to less than 2-fold for the Y256A TERT variant (Figure 4E). In other words, a single Y256A substitution increased rGTP insertion efficiency by 18,000-fold, abolishing almost all sugar discrimination. In a cellular environment, where rNTPs are at much higher concentrations than dNTPs, WT TERT would insert rGTP over 100-fold times less efficiently than dGTP. In contrast, TERT Y256A under cellular conditions would insert rGTP 77-fold times more efficiently than dGTP (Figure 4F; Traut, 1994).

Figure 4

Download asset Open asset

We next verified that this ablation in sugar discrimination was due to specific changes in the TERT active site rather than global rearrangements of the enzyme. To test for structural rearrangements, we crystallized the pre-nucleotide binary state of TERT Y256A (state A₆), and saw minimal structural differences compared to the WT protein (Figure 4G–J). The position of the primer terminus was not changed, and catalytic residues D251, D343, and D344 were in position to catalyze the nucleotidyl transferase reaction (Figure 4H). Upon closer examination of the active site pocket, the substitution of Y256 with alanine resulted in a more open nucleotide binding pocket (Figure 4H and I). The distance from the C2 carbon of the dGpCpp to residue 256 shifted from 3.3 Å in WT TERT to 5.7 Å in TERT Y256A, showing that the TERT Y256A has much more room to accommodate the 2’-OH (Figure 4J). Taken as a whole, these results indicate Y256 clashes with the 2’-OH of rNTPs to provide sugar discrimination and is the steric gate in telomerase.

To determine if human telomerase uses a similar mechanism to discriminate against rNTP insertion, we implemented human telomerase activity assays (Xi and Cech, 2014). In these assays, 1.5 telomeric repeats with the sequence TTAGGGTTAG were incubated with 50 µM of either all four dNTPs or all four rNTPs and purified 3xFLAG tagged human telomerase overexpressed with hTR. We performed these tests with both WT telomerase and a telomerase Y717A variant, which is the homologous residue to tcTERT Y256. WT telomerase showed robust primer extension in the presence of dNTPs, with ~10% of the primer extended into product over the course of 30 min (Figure 5A,B). Similarly, with all four dNTPs, the Y717A variant reached ~7% primer extension in the same amount of time (Figure 5A,B). In contrast, when we incubated WT telomerase with all four rNTPs rather than dNTPs, we observed very low (<1%) primer extension after 30 min, suggesting that human telomerase discriminates against rNTPs, similar to tcTERT (Figure 5C,D). When we performed the same telomeric extension assay with the steric gate variant (Y717A), we observed that the primer extension was increased 3-fold compared to WT hTERT in the presence of rNTPs (Figure 5C,D). These results indicate the conserved residue Y717 in hTERT (Supplementary file 1, Table 1a) is the steric gate in human telomerase. Interestingly, in both WT and Y717A telomerase, minimal insertion past the first telomeric repeat was observed, which suggests the presence of rNTPs in telomere strands may inhibit the telomerase translocation step (Figure 5C).

Figure 5

Download asset Open asset

We next assessed if more subtle alterations in the nucleotide mixture would also cause inhibition of telomerase extension. By substituting one rNTP into the nucleotide mix at a time, we could determine the effects of inserting one, two, or three rNTPs inserted per repeat (with rATP, rUTP, and rGTP, respectively). In each case, telomerase processivity was reduced, with no bands evident past the second telomeric repeat (Figure 5E). The inhibitory effect seemed to depend on the number of rNTPs inserted per repeat, with rGTP presence showing the greatest inhibition. For the steric gate Y717A mutant telomerase, the effect of rNTPs on telomerase’s processivity were much less pronounced. In the most extreme case of three rNTPs present per repeat, extension products are evident well into the second repeat, in contrast to the WT telomerase which had almost no insertion events (Figure 5E). We hypothesize that the rGTP insertion drastically inhibits WT telomerase because the first two insertions in the repeat are templated by rC. Therefore, the first event would need to be a rNTP insertion, followed by another rNTP insertion from a potentially unstable primer terminus. We are unable to decipher if inhibitory effects are due to the number of ribonucleotides per repeat, sequence-dependent inhibition, or a combination of both. In contrast to rGTP, telomerase is able to incorporate multiple repeats when rATP is present, albeit at a reduced efficiency compared to dNTPs (Figure 5E).

Within these primer extension activity assays, the effects of rNTP insertions can also be observed at the single nucleotide level. For rATP insertion with WT telomerase, we observed a buildup in substrates one nucleotide shorter than where the rNTP insertion would occur, composing ~60% of the total product formation (Figure 5F). This could be explained by the poor catalytic efficiency of telomerase for rATP insertion causing the enzyme to stall directly before the rATP insertion event. In contrast to the WT telomerase, the Y717A variant did not stall at the rATP insertion event. Interestingly, rNTPs inhibited translocation in both Y717A and WT telomerase, implying that telomerase possesses rNTP discrimination mechanisms beyond the level of single nucleotide incorporations (Figure 5E,F). The agreement between the results of the tcTERT and hTERT points towards a universal mechanism of sugar discrimination by any telomerase homolog with a tyrosine in this conserved position (Supplementary file 1, Table 1a).

Diffraction data have been deposited in PDB under the accession code 6USO, 6USP, 6USQ, and 6US.

1. 1. Freudenthal BD
   2. Schaich MA

   (2020) RCSB Protein Data Bank

   ID 6USO. Telomerase Reverse Transcriptase prenucleotide binary complex, TERT:DNA.

   https://www.rcsb.org/structure/6USO
2. 1. Freudenthal BD
   2. Schaich MA

   (2020) RCSB Protein Data Bank

   ID 6USR. Telomerase Reverse Transcriptase ternary complex, TERT:DNA:dGpCpp.

   https://www.rcsb.org/structure/6USR
3. 1. Freudenthal BD
   2. Schaich MA

   (2020) RCSB Protein Data Bank

   ID 6USP. Telomerase Reverse Transcriptase product complex, TERT:DNA.

   https://www.rcsb.org/structure/6USP
4. 1. Freudenthal BD
   2. Schaich MA
   3. Khoang TH

   (2020) RCSB Protein Data Bank

   ID 6USQ. Telomerase Reverse Transcriptase binary complex with Y256A mutation, TERT:DNA.

   https://www.rcsb.org/structure/6USQ

1. 1. Adams PD
   2. Afonine PV
   3. Bunkóczi G
   4. Chen VB
   5. Davis IW
   6. Echols N
   7. Headd JJ
   8. Hung LW
   9. Kapral GJ
   10. Grosse-Kunstleve RW
   11. McCoy AJ
   12. Moriarty NW
   13. Oeffner R
   14. Read RJ
   15. Richardson DC
   16. Richardson JS
   17. Terwilliger TC
   18. Zwart PH

   (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution

   Acta Crystallographica Section D Biological Crystallography 66:213–221.

   https://doi.org/10.1107/S0907444909052925

   • PubMed
   • Google Scholar
2. 1. Basel-Vanagaite L
   2. Dokal I
   3. Tamary H
   4. Avigdor A
   5. Garty BZ
   6. Volkov A
   7. Vulliamy T

   (2008) Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations

   Haematologica 93:943–944.

   https://doi.org/10.3324/haematol.12317

   • PubMed
   • Google Scholar
3. 1. Batra VK
   2. Beard WA
   3. Shock DD
   4. Krahn JM
   5. Pedersen LC
   6. Wilson SH

   (2006) Magnesium-induced assembly of a complete DNA polymerase catalytic complex

   Structure 14:757–766.

   https://doi.org/10.1016/j.str.2006.01.011

   • PubMed
   • Google Scholar
4. 1. Baumann P
   2. Cech TR

   (2001) Pot1, the putative telomere end-binding protein in fission yeast and humans

   Science 292:1171–1175.

   https://doi.org/10.1126/science.1060036

   • PubMed
   • Google Scholar
5. 1. Beard WA
   2. Shock DD
   3. Batra VK
   4. Prasad R
   5. Wilson SH

   (2014) Substrate-induced DNA polymerase β activation

   Journal of Biological Chemistry 289:31411–31422.

   https://doi.org/10.1074/jbc.M114.607432

   • PubMed
   • Google Scholar
6. 1. Biertümpfel C
   2. Zhao Y
   3. Kondo Y
   4. Ramón-Maiques S
   5. Gregory M
   6. Lee JY
   7. Masutani C
   8. Lehmann AR
   9. Hanaoka F
   10. Yang W

   (2010) Structure and mechanism of human DNA polymerase eta

   Nature 465:1044–1048.

   https://doi.org/10.1038/nature09196

   • PubMed
   • Google Scholar
7. 1. Blackburn EH
   2. Gall JG

   (1978) A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena

   Journal of Molecular Biology 120:33–53.

   https://doi.org/10.1016/0022-2836(78)90294-2

   • PubMed
   • Google Scholar
8. 1. Blasco MA

   (2005) Telomeres and human disease: ageing, Cancer and beyond

   Nature Reviews Genetics 6:611–622.

   https://doi.org/10.1038/nrg1656

   • PubMed
   • Google Scholar
9. 1. Brown JA
   2. Zhang L
   3. Sherrer SM
   4. Taylor J-S
   5. Burgers PMJ
   6. Suo Z

   (2010) Pre-Steady-State kinetic analysis of truncated and Full-Length Saccharomyces cerevisiae DNA polymerase eta

   Journal of Nucleic Acids 2010:1–11.

   https://doi.org/10.4061/2010/871939

   • Google Scholar
10. 1. Brown JA
    2. Suo Z

    (2011) Unlocking the sugar "steric gate" of DNA polymerases

    Biochemistry 50:1135–1142.

    https://doi.org/10.1021/bi101915z

    • PubMed
    • Google Scholar
11. 1. Burge S
    2. Parkinson GN
    3. Hazel P
    4. Todd AK
    5. Neidle S

    (2006) Quadruplex DNA: sequence, topology and structure

    Nucleic Acids Research 34:5402–5415.

    https://doi.org/10.1093/nar/gkl655

    • PubMed
    • Google Scholar
12. 1. Cavanaugh NA
    2. Beard WA
    3. Wilson SH

    (2010) DNA polymerase beta ribonucleotide discrimination: insertion, misinsertion, extension, and coding

    The Journal of Biological Chemistry 285:24457–24465.

    https://doi.org/10.1074/jbc.M110.132407

    • PubMed
    • Google Scholar
13. 1. Chen VB
    2. Arendall WB
    3. Headd JJ
    4. Keedy DA
    5. Immormino RM
    6. Kapral GJ
    7. Murray LW
    8. Richardson JS
    9. Richardson DC

    (2010) MolProbity: all-atom structure validation for macromolecular crystallography

    Acta Crystallographica Section D Biological Crystallography 66:12–21.

    https://doi.org/10.1107/S0907444909042073

    • PubMed
    • Google Scholar
14. 1. Chen Y
    2. Podlevsky JD
    3. Logeswaran D
    4. Chen JJ

    (2018) A single nucleotide incorporation step limits human telomerase repeat addition activity

    The EMBO Journal 37:e97953.

    https://doi.org/10.15252/embj.201797953

    • PubMed
    • Google Scholar
15. 1. Collins K
    2. Greider CW

    (1995) Utilization of ribonucleotides and RNA primers by Tetrahymena telomerase

    The EMBO Journal 14:5422–5432.

    https://doi.org/10.1002/j.1460-2075.1995.tb00226.x

    • PubMed
    • Google Scholar
16. 1. de Lange T

    (2005) Shelterin: the protein complex that shapes and safeguards human telomeres

    Genes & Development 19:2100–2110.

    https://doi.org/10.1101/gad.1346005

    • PubMed
    • Google Scholar
17. 1. Diaz de Leon A
    2. Cronkhite JT
    3. Katzenstein AL
    4. Godwin JD
    5. Raghu G
    6. Glazer CS
    7. Rosenblatt RL
    8. Girod CE
    9. Garrity ER
    10. Xing C
    11. Garcia CK

    (2010) Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations

    PLOS ONE 5:e10680.

    https://doi.org/10.1371/journal.pone.0010680

    • PubMed
    • Google Scholar
18. 1. Doublié S
    2. Sawaya MR
    3. Ellenberger T

    (1999) An open and closed case for all polymerases

    Structure 7:R31–R35.

    https://doi.org/10.1016/S0969-2126(99)80017-3

    • PubMed
    • Google Scholar
19. 1. Emsley P
    2. Cowtan K

    (2004) Coot: model-building tools for molecular graphics

    Acta Crystallographica. Section D, Biological Crystallography 60:2126–2132.

    https://doi.org/10.1107/S0907444904019158

    • PubMed
    • Google Scholar
20. 1. Fay MM
    2. Lyons SM
    3. Ivanov P

    (2017) RNA G-Quadruplexes in biology: principles and molecular mechanisms

    Journal of Molecular Biology 429:2127–2147.

    https://doi.org/10.1016/j.jmb.2017.05.017

    • PubMed
    • Google Scholar
21. 1. Fouquerel E
    2. Lormand J
    3. Bose A
    4. Lee HT
    5. Kim GS
    6. Li J
    7. Sobol RW
    8. Freudenthal BD
    9. Myong S
    10. Opresko PL

    (2016) Oxidative guanine base damage regulates human telomerase activity

    Nature Structural & Molecular Biology 23:1092–1100.

    https://doi.org/10.1038/nsmb.3319

    • PubMed
    • Google Scholar
22. 1. Garforth SJ
    2. Wu YY
    3. Prasad VR

    (2006) Structural features of mouse telomerase RNA are responsible for the lower activity of mouse telomerase versus human telomerase

    Biochemical Journal 397:399–406.

    https://doi.org/10.1042/BJ20060456

    • PubMed
    • Google Scholar
23. 1. Gillis AJ
    2. Schuller AP
    3. Skordalakes E

    (2008) Structure of the tribolium castaneum telomerase catalytic subunit TERT

    Nature 455:633–637.

    https://doi.org/10.1038/nature07283

    • PubMed
    • Google Scholar
24. 1. Gleghorn ML
    2. Davydova EK
    3. Basu R
    4. Rothman-Denes LB
    5. Murakami KS

    (2011) X-ray crystal structures elucidate the nucleotidyl transfer reaction of transcript initiation using two nucleotides

    PNAS 108:3566–3571.

    https://doi.org/10.1073/pnas.1016691108

    • PubMed
    • Google Scholar
25. 1. Greider CW
    2. Blackburn EH

    (1987) The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity

    Cell 51:887–898.

    https://doi.org/10.1016/0092-8674(87)90576-9

    • PubMed
    • Google Scholar
26. 1. Hayflick L
    2. Moorhead PS

    (1961) The serial cultivation of human diploid cell strains

    Experimental Cell Research 25:585–621.

    https://doi.org/10.1016/0014-4827(61)90192-6

    • PubMed
    • Google Scholar
27. 1. Jafri MA
    2. Ansari SA
    3. Alqahtani MH
    4. Shay JW

    (2016) Roles of telomeres and telomerase in Cancer, and advances in telomerase-targeted therapies

    Genome Medicine 8:69.

    https://doi.org/10.1186/s13073-016-0324-x

    • PubMed
    • Google Scholar
28. 1. Jiang J
    2. Wang Y
    3. Sušac L
    4. Chan H
    5. Basu R
    6. Zhou ZH
    7. Feigon J

    (2018) Structure of telomerase with telomeric DNA

    Cell 173:1179–1190.

    https://doi.org/10.1016/j.cell.2018.04.038

    • PubMed
    • Google Scholar
29. 1. Kabsch W

    (2010) XDS

    Acta Crystallographica. Section D, Biological Crystallography 66:125–132.

    https://doi.org/10.1107/S0907444909047337

    • PubMed
    • Google Scholar
30. 1. Kim NW
    2. Piatyszek MA
    3. Prowse KR
    4. Harley CB
    5. West MD
    6. Ho PL
    7. Coviello GM
    8. Wright WE
    9. Weinrich SL
    10. Shay JW

    (1994) Specific association of human telomerase activity with immortal cells and Cancer

    Science 266:2011–2015.

    https://doi.org/10.1126/science.7605428

    • PubMed
    • Google Scholar
31. 1. Lee M
    2. Teber ET
    3. Holmes O
    4. Nones K
    5. Patch AM
    6. Dagg RA
    7. Lau LMS
    8. Lee JH
    9. Napier CE
    10. Arthur JW
    11. Grimmond SM
    12. Hayward NK
    13. Johansson PA
    14. Mann GJ
    15. Scolyer RA
    16. Wilmott JS
    17. Reddel RR
    18. Pearson JV
    19. Waddell N
    20. Pickett HA

    (2018) Telomere sequence content can be used to determine ALT activity in tumours

    Nucleic Acids Research 46:4903–4918.

    https://doi.org/10.1093/nar/gky297

    • PubMed
    • Google Scholar
32. 1. Li Y
    2. Breaker RR

    (1999) Kinetics of RNA degradation by specific base catalysis of transesterification involving the 2‘-Hydroxyl Group

    Journal of the American Chemical Society 121:5364–5372.

    https://doi.org/10.1021/ja990592p

    • Google Scholar
33. 1. McCulloch SD
    2. Kunkel TA

    (2008) The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases

    Cell Research 18:148–161.

    https://doi.org/10.1038/cr.2008.4

    • PubMed
    • Google Scholar
34. 1. Mender I
    2. Gryaznov S
    3. Dikmen ZG
    4. Wright WE
    5. Shay JW

    (2015) Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine

    Cancer Discovery 5:82–95.

    https://doi.org/10.1158/2159-8290.CD-14-0609

    • PubMed
    • Google Scholar
35. 1. Meyerson M

    (1998) Telomerase enzyme activation and human cell immortalization

    Toxicology Letters 102-103:41–45.

    https://doi.org/10.1016/S0378-4274(98)00278-1

    • PubMed
    • Google Scholar
36. 1. Mitchell M
    2. Gillis A
    3. Futahashi M
    4. Fujiwara H
    5. Skordalakes E

    (2010) Structural basis for telomerase catalytic subunit TERT binding to RNA template and telomeric DNA

    Nature Structural & Molecular Biology 17:513–518.

    https://doi.org/10.1038/nsmb.1777

    • PubMed
    • Google Scholar
37. 1. Moyzis RK
    2. Buckingham JM
    3. Cram LS
    4. Dani M
    5. Deaven LL
    6. Jones MD
    7. Meyne J
    8. Ratliff RL
    9. Wu JR

    (1988) A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes

    PNAS 85:6622–6626.

    https://doi.org/10.1073/pnas.85.18.6622

    • PubMed
    • Google Scholar
38. 1. Nandakumar J
    2. Podell ER
    3. Cech TR

    (2010) How telomeric protein POT1 avoids RNA to achieve specificity for single-stranded DNA

    PNAS 107:651–656.

    https://doi.org/10.1073/pnas.0911099107

    • PubMed
    • Google Scholar
39. 1. Nelson ND
    2. Bertuch AA

    (2012) Dyskeratosis congenita as a disorder of telomere maintenance

    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 730:43–51.

    https://doi.org/10.1016/j.mrfmmm.2011.06.008

    • Google Scholar
40. 1. Nguyen THD
    2. Tam J
    3. Wu RA
    4. Greber BJ
    5. Toso D
    6. Nogales E
    7. Collins K

    (2018) Cryo-EM structure of substrate-bound human telomerase holoenzyme

    Nature 557:190–195.

    https://doi.org/10.1038/s41586-018-0062-x

    • PubMed
    • Google Scholar
41. 1. Nick McElhinny SA
    2. Watts BE
    3. Kumar D
    4. Watt DL
    5. Lundström EB
    6. Burgers PM
    7. Johansson E
    8. Chabes A
    9. Kunkel TA

    (2010) Abundant ribonucleotide incorporation into DNA by yeast replicative polymerases

    PNAS 107:4949–4954.

    https://doi.org/10.1073/pnas.0914857107

    • PubMed
    • Google Scholar
42. 1. Niederer RO
    2. Zappulla DC

    (2015) Refined secondary-structure models of the core of yeast and human telomerase RNAs directed by SHAPE

    RNA 21:254–261.

    https://doi.org/10.1261/rna.048959.114

    • PubMed
    • Google Scholar
43. 1. Nowotny M
    2. Gaidamakov SA
    3. Crouch RJ
    4. Yang W

    (2005) Crystal structures of RNase H bound to an RNA/DNA hybrid: substrate specificity and metal-dependent catalysis

    Cell 121:1005–1016.

    https://doi.org/10.1016/j.cell.2005.04.024

    • PubMed
    • Google Scholar
44. 1. Olovnikov AM

    (1973) A theory of marginotomy the incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon

    Journal of Theoretical Biology 41:181–190.

    https://doi.org/10.1016/0022-5193(73)90198-7

    • PubMed
    • Google Scholar
45. 1. Petrova OA
    2. Mantsyzov AB
    3. Rodina EV
    4. Efimov SV
    5. Hackenberg C
    6. Hakanpää J
    7. Klochkov VV
    8. Lebedev AA
    9. Chugunova AA
    10. Malyavko AN
    11. Zatsepin TS
    12. Mishin AV
    13. Zvereva MI
    14. Lamzin VS
    15. Dontsova OA
    16. Polshakov VI

    (2018) Structure and function of the N-terminal domain of the yeast telomerase reverse transcriptase

    Nucleic Acids Research 46:1525–1540.

    https://doi.org/10.1093/nar/gkx1275

    • PubMed
    • Google Scholar
46. 1. Powers KT
    2. Washington MT

    (2017) Analyzing the catalytic activities and interactions of eukaryotic translesion synthesis polymerases

    Methods in Enzymology 592:329–356.

    https://doi.org/10.1016/bs.mie.2017.04.002

    • PubMed
    • Google Scholar
47. 1. Ramakrishnan S
    2. Sharma HW
    3. Farris AD
    4. Kaufman KM
    5. Harley JB
    6. Collins K
    7. Pruijn GJ
    8. van Venrooij WJ
    9. Martin ML
    10. Narayanan R

    (1997) Characterization of human telomerase complex

    PNAS 94:10075–10079.

    https://doi.org/10.1073/pnas.94.19.10075

    • PubMed
    • Google Scholar
48. 1. Sawaya MR
    2. Pelletier H
    3. Kumar A
    4. Wilson SH
    5. Kraut J

    (1994) Crystal structure of rat DNA polymerase beta: evidence for a common polymerase mechanism

    Science 264:1930–1935.

    https://doi.org/10.1126/science.7516581

    • PubMed
    • Google Scholar
49. 1. Sayed ME
    2. Cheng A
    3. Yadav GP
    4. Ludlow AT
    5. Shay JW
    6. Wright WE
    7. Jiang QX

    (2019) Catalysis-dependent inactivation of human telomerase and its reactivation by intracellular telomerase-activating factors (iTAFs)

    Journal of Biological Chemistry 294:11579–11596.

    https://doi.org/10.1074/jbc.RA118.007234

    • PubMed
    • Google Scholar
50. 1. Schmidt JC
    2. Zaug AJ
    3. Cech TR

    (2016) Live cell imaging reveals the dynamics of telomerase recruitment to telomeres

    Cell 166:1188–1197.

    https://doi.org/10.1016/j.cell.2016.07.033

    • PubMed
    • Google Scholar
51. 1. Schmidt T
    2. Tian L
    3. Clore GM

    (2018) Probing conformational states of the finger and thumb subdomains of HIV-1 reverse transcriptase using double Electron-Electron resonance electron paramagnetic resonance spectroscopy

    Biochemistry 57:489–493.

    https://doi.org/10.1021/acs.biochem.7b01035

    • PubMed
    • Google Scholar
52. 1. Schneider CA
    2. Rasband WS
    3. Eliceiri KW

    (2012) NIH image to ImageJ: 25 years of image analysis

    Nature Methods 9:671–675.

    https://doi.org/10.1038/nmeth.2089

    • PubMed
    • Google Scholar
53. 1. Sparks JL
    2. Chon H
    3. Cerritelli SM
    4. Kunkel TA
    5. Johansson E
    6. Crouch RJ
    7. Burgers PM

    (2012) RNase H2-initiated ribonucleotide excision repair

    Molecular Cell 47:980–986.

    https://doi.org/10.1016/j.molcel.2012.06.035

    • PubMed
    • Google Scholar
54. 1. Steczkiewicz K
    2. Zimmermann MT
    3. Kurcinski M
    4. Lewis BA
    5. Dobbs D
    6. Kloczkowski A
    7. Jernigan RL
    8. Kolinski A
    9. Ginalski K

    (2011) Human telomerase model shows the role of the TEN domain in advancing the double Helix for the next polymerization step

    PNAS 108:9443–9448.

    https://doi.org/10.1073/pnas.1015399108

    • PubMed
    • Google Scholar
55. 1. Stefl R
    2. Spacková N
    3. Berger I
    4. Koca J
    5. Sponer J

    (2001) Molecular dynamics of DNA quadruplex molecules containing inosine, 6-thioguanine and 6-thiopurine

    Biophysical Journal 80:455–468.

    https://doi.org/10.1016/S0006-3495(01)76028-6

    • PubMed
    • Google Scholar
56. 1. Steitz TA

    (1999) DNA polymerases: structural diversity and common mechanisms

    Journal of Biological Chemistry 274:17395–17398.

    https://doi.org/10.1074/jbc.274.25.17395

    • PubMed
    • Google Scholar
57. 1. Traut TW

    (1994) Physiological concentrations of purines and pyrimidines

    Molecular and Cellular Biochemistry 140:1–22.

    https://doi.org/10.1007/BF00928361

    • PubMed
    • Google Scholar
58. 1. Watson JD

    (1972) Origin of concatemeric T7 DNA

    Nature New Biology 239:197–201.

    https://doi.org/10.1038/newbio239197a0

    • PubMed
    • Google Scholar
59. 1. Winn MD
    2. Ballard CC
    3. Cowtan KD
    4. Dodson EJ
    5. Emsley P
    6. Evans PR
    7. Keegan RM
    8. Krissinel EB
    9. Leslie AG
    10. McCoy A
    11. McNicholas SJ
    12. Murshudov GN
    13. Pannu NS
    14. Potterton EA
    15. Powell HR
    16. Read RJ
    17. Vagin A
    18. Wilson KS

    (2011) Overview of the CCP4 suite and current developments

    Acta Crystallographica. Section D, Biological Crystallography 67:235–242.

    https://doi.org/10.1107/S0907444910045749

    • PubMed
    • Google Scholar
60. 1. Xi L
    2. Cech TR

    (2014) Inventory of telomerase components in human cells reveals multiple subpopulations of hTR and hTERT

    Nucleic Acids Research 42:8565–8577.

    https://doi.org/10.1093/nar/gku560

    • PubMed
    • Google Scholar

Acceptance summary:

The reviewers and the reviewing editor agreed that this work is significant because it is not known how telomerase selects the correct nucleotide for insertion into the telomeric repeat from a pool of nucleotide with various sugars and base pairing properties. This work is an important advance defining (at least in vitro) nucleotide selection by telomerase through the first high resolution crystal structures of Tribolium castaneum telomerase reverse transcriptase (TERT) throughout its catalytic cycle and characterization of the Tribolium and human TERT kinetics. The authors solved the three structures of Tribolium TERT in complex with a DNA/RNA duplex with 1 nucleotide (nt) overhang, the same duplex with a non-hydrolyzable analog of dGTP and a product DNA/RNA duplex. The most important new finding was that there is a steric gate that allows TERT to discriminate dNTPs from rNTPs. The authors show that this residue (Y717) serves similar functions in human telomerase.

Decision letter after peer review:

Thank you for submitting your article "Mechanisms of nucleotide selection by telomerase" for consideration by eLife. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Cynthia Wolberger as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The reviewers and the reviewing editor agreed that this work is significant because it is not known how telomerase selects the correct nucleotide for insertion into the telomeric repeat from a pool of nucleotide with various sugars and base pairing properties. This work is an important advance defining (at least in vitro) nucleotide selection by telomerase through the first high resolution crystal structures of Triboliumcastaneum telomerase reverse transcriptase (TERT) throughout its catalytic cycle and characterization of the Tribolium and human TERT kinetics. The authors solved the three structures of Tribolium TERT in complex with a DNA/RNA duplex with 1 nucleotide (nt) overhang, the same duplex with a non-hydrolyzable analog of dGTP and a product DNA/RNA duplex. The most novel finding was a steric gate which allows TERT to discriminate dNTPs from rNTPs and the authors show that this residue (Y717) serves similar functions in human telomerase.

The reviewers and the reviewing editor, however feel that there are insufficient discussion and comparison with other structural and biochemical work, especially in the light of similarity between these new reported structures and those published by Gillis et al., 2008 and Mitchell et al., 2010, with the product state being almost the same as that reported by Mitchell et al., 2010. There is also a question of state I designation that needs to be addressed experimentally.

Essential revisions:

Significant revisions that will require new experiments:

The main concern of the reviewers was related to "state I" designation. The authors chose a substrate where the RNA primer has just one 3' nucleotide overhang, perhaps to prevent subsequent cycles of catalysis. But since tcTERT uses RNA primers with up to 6 nt overhang, it is conceivable that the template-TERT conformation, especially the RNA-interacting residues could be very different between 1 and 6 templating bases. In a natural telomerase RNP, the RNA template threads through the TERT ring. The reviewers questioned whether "state I" described in the paper with only 1 nt overhang truly represents state I. In the recent Tetrahymena EM structure at 4.8 Å (Jiang et al., Science 2018), a stretch of the locked-DNA substrate is bound to the RNA template, which may be more representative of state I in the cycle. For the main conclusions of this paper to be valid, the authors need to provide a new structure of state I with the 6 nt overhang RNA primer (preferred) or show that the structure they have behaves the same way as State I.

Other significant revisions:

1) Wu et al., (EMBO 2017) extensively characterized how the DNA substrate is handled during each cycle of repeat synthesis and suggested a more detailed catalytic cycle than what is proposed in Figure 1 here. It involved partial duplex melting before the synthesis reaches the template 5' end, allowing translocation to occur. It has also been shown that the kinetics of the addition of each nt within each telomeric repeat is not the same (Chen et al., 2018). So far the structures and kinetics have only been done with one single addition of dGTP in this work, which will be different for other nucleotides of the repeat. This point needs to be carefully addressed.

2) The authors identified critical residues for the catalytic activity and fidelity, revealing similarities and differences with other DNA polymerases. This said, while Tribolium TERT provides a good model system for studying TERT structure, it lacks the TEN domain and a large part of the IFD, which have been shown to be crucial for TERT activity and processivity in human and Tetrahymena. This major difference and whether the kinetics observations can be generalized to other telomerases warrants a discussion.

3) The Y717 steric gate is required for discriminating dNTPs from rNTPs, which is nicely shown in the human telomerase case. There is indeed a correlation between the number nucleotide in the repeat and the rate of incorporation. However, it is intriguing that the enzyme is still able to incorporate a couple of repeats with rATP. This suggests that in the human case the rATP in this position can be tolerated to some extent. Besides the sugar gate, could the base identity have some effects too?

4) The description of critical residues surrounding RNA as well as incoming nucleotide is often too vague. More modeling or description is needed. For instance, how does R194 relocation/move between different state?

5) Please provide details to those who are not familiar with T. casteneum telomerase such as the TERT and TR molecular weights and how they differ from human or mouse telomerase. Also the authors should elaborate more on the TR version for T. casteneum. We assume as readers that the authors could not co-crystalize with "tcTR" for similar reasons as the field is not able to crystalize human hTR + hTERT. Please provide some background on that (perhaps in the Introduction).

6) It seems that the authors generated the RNA:DNA hybrid substrate prior to incubating with tcTERT. What was the reason for this? Could they incubate the RNA 16-mer with tcTERT to allow that complex to assemble and then add the 15-mer complimentary DNA substrate? Would they see the same results? Technically speaking the substrate for telomerase is the DNA (nucleotide or single stranded). The RNA is a part of the enzymatic complex.

7) Subsection “Product complex”. It makes sense that there are minimal rearrangements since it could be predicted that the majority of movement is in the RNA subunit of telomerase (which is missing in this model). However, a key question is to know how it stays on and translocates after a full hexameric repeat is added. The authors may want to review a recent paper (J. Biol. Chem., 294(30):11579-11588, 2019). This work provides a more macro look at the telomerase catalytic cycle that may provide some insights into the present studies.

8) Please elaborate on the chemistry step vs nucleotide binding step.

9) Subsection “The steric gate of telomerase” paragraph three. Please include the details of the telomerase used. Was a recombinant telomerase with 3xFLAG tag and overexpressed hTR used? This is important as we have now seen that the tags used for telomerase play a role for in-vitro and in-vivo activity.

10) Figure 5C. If you generated a custom single-stranded substrate with dNTPs and rNTPs, would you even lose that first extension? Maybe an experiment like this will test the assumption that it "may inhibit the telomerase translocation step."

11) Subsection “The steric gate of telomerase” paragraph four. rGTP displayed the greatest inhibition. Is this because 3Gs are in the hexameric repeat or is this due to something else? Some discussion on this would be helpful.

12) While all alterations resulted in reduction of telomere extension by telomerase, did any alterations tested enhance telomere extension (e.g. decreased pausing, improved processivity etc). This should be mentioned in the Discussion.

13) Any evidence in the current series of experiment that the alterations of inserted ribonucleotides causes DNA damage or lack of shelterin protection. While this has been shown by others in cells using altered nucleotide insertion into telomeres, there are no cell-based studies in the present studies to confirm or progress much of the speculation in the Discussion since all experiments in the present studies use a somewhat artificial in vitro (test tube) approach. For example, do altered ribonucleotides persist in telomeres and is there any evidence that RER removes them? Also, what is the evidence that a single misinsertion every 10kb would prevent shelterin binding or disrupt G-quadruplex stability? Even with these concerns, the studies are important to help future studies confirm and extend these finding.

Essential revisions:

Significant revisions that will require new experiments:

The main concern of the reviewers was related to "state I" designation. The authors chose a substrate where the RNA primer has just one 3' nucleotide overhang, perhaps to prevent subsequent cycles of catalysis. But since tcTERT uses RNA primers with up to 6 nt overhang, it is conceivable that the template-TERT conformation, especially the RNA-interacting residues could be very different between 1 and 6 templating bases. In a natural telomerase RNP, the RNA template threads through the TERT ring. The reviewers questioned whether "state I" described in the paper with only 1 nt overhang truly represents state I. In the recent Tetrahymena EM structure at 4.8 Å (Jiang et al., Science 2018), a stretch of the locked-DNA substrate is bound to the RNA template, which may be more representative of state I in the cycle. For the main conclusions of this paper to be valid, the authors need to provide a new structure of state I with the 6 nt overhang RNA primer (preferred) or show that the structure they have behaves the same way as State I.

We would like to first apologize to the reviewers and reviewing editor for the confusion in regards to Figure 1A and specifically our nomenclature of “state I”. This figure was generated with simplicity in mind and clearly this was a confusing error on our behalf. To address this error, we have done the following: (1) remade Figure 1A with distinct nomenclature for each step in the catalytic cycle; (2) made an additional supplemental figure (Figure 1—figure supplement 3) that describes all 18 steps during the telomerase catalytic cycle for one telomeric repeat addition; and (3) clearly indicated which structural state we are describing in the telomerase catalytic cycle for each reported structure. These changes are expanded upon below.

We wish to thank the reviewers for their suggestion of an additional structure, and agree that each overhang length from one to six will result in unique TERT structural states, with a combined 18 structures needed in total. To this end, we spent over a year aggressively screening ~70,000 crystallization conditions. This involved screening multiple TERT protein constructs and over 40 different nucleic acid substrates of various different overhang lengths, hairpins, and substrates with overhangs on both sides. Moreover, we also employed the resources and expertise of the KU Lawrence campus structural biology core to screen additional crystallization conditions and protein constructs to no avail. So far, the only nucleic acid substrate that has successfully yielded structural information was the one featured in this paper. Even after this initial hit was obtained, we spent months optimizing the condition, and had to screen through hundreds of crystals at the synchrotron Xray source to get the 2.5 Å resolution presented here. Therefore, even if we were able to immediately get an additional novel crystal hit, a new TERT structure could take upwards of a year to generate at an appreciable resolution. It is worth mentioning, prior to the lab closing down for COVID-19, we were actively working to obtain additional high-resolution structural snapshots with various substrates for follow-up studies and will continue this once the lab and synchrotron reopen as we feel novel structural snapshots at each step is a pressing question in the telomerase field.

Instead of obtaining a new crystal structure for the revised manuscript, we would like to emphasize that, although our structure has a one nucleotide gap instead of six, we feel it provides significant insight into the telomerase catalytic cycle at each step. This is because the pre-nucleotide bound category is visited 6 times (Figure 1A and Figure 1—figure supplement 3, steps A_1-6) prior to the telomerase translocation step. In other words, although the templating RNA base shifts between each of the 6 insertion positions, the TERT active site must go through the general cycle of: free nucleotide binding pocket → nucleotide triphosphate bound within the active site → nucleotide insertion (i.e. product formation). In the initial submission, we had attempted to group all 18 structural states based on the components in the TERT active site, but in response to these peer reviews we have now clarified our catalytic cycle to explicitly include all 18 states (see Figure 1—figure supplement 3). Furthermore, we have changed the labeling scheme in the text to now identify our structural snapshots as states A_6, B₆, and C₆. In all other current structures of TERT (including Mitchell et al., 2010, and Jiang et al., 2018), the TERT active site is positioned at the primer terminus, with the last inserted nucleotide still in the nucleotide binding pocket, which are all members of the final product step of nucleotide addition or the “C” category of the structural states in Figure 1—figure supplement 3. We think this new labeling scheme highlights that we are presenting two new categories of structural states, “A” and “B”. Furthermore, although structural information for category A and B structures are unknown (prenucleotide and ternary), we can compare our C category structure to the lower resolution cryo-EM structure of Tetrahymena thermophila telomerase (Jiang et al., 2018). The positions of key active site amino acids from ttTERT state C₃ closely align with our state C₆ (RMSD = 0.83, see Author response image 1, Figure 1—figure supplement 3 for state designations). This structural agreement between different states and homologs implies that active site contacts are similar throughout all 6 overhang lengths.

Author response image 1

Download asset Open asset

Finally, previous kinetic studies provide evidence that the structural states that we have presented in this manuscript are more representative of a typical telomerase catalytic cycle than structures of the first insertion event (which we had mistakenly called state I in the initial submission). In a recent EMBO paper (2018, Chen et al.), steady-state kinetics were performed for all six templating positions. In this study, it was shown that the K_M values for the incoming nucleotide vary by a maximum of ~30-fold depending on the registry position (i.e. overhang length). These values were 120 μM for the 6-nucleotide overhang, and 4, 31, and 5 μM for four, two, and single nucleotide overhangs, respectively. Of note, out of all six templating positions, the substrate with six templating bases exhibited altered kinetics compared to the other 5 positions. Thus, the structural snapshot we report here (one nucleotide overhang) is likely representative of a typical catalytic cycle (i.e. 15/18 structural states of A₂ to C₆, Figure 1—figure supplement 3) as compared to a six-nucleotide overhang that is representative of only 3/18 structural states.

In summary, we sincerely apologize for our error in the description of state I in the initial submission and have corrected this in the revised manuscript. While we would like to obtain a structure with a six nucleotide overhang, we are not confident this will be attainable and will likely require a follow-up study on all eighteen catalytic states. Although this structural information is not available, comparisons to TERT structures with a different overhang length (Author response image 1) and the kinetics of various overhang lengths (performed in Chen et al., 2018) give us confidence that the catalytic cycle presented here represents a typical catalytic cycle for telomerase. Furthermore, the overall trends we describe in terms of fidelity, sugar selectivity, and nucleotide binding affinity are based on observed differences of up to four orders of magnitude and likely would not be altered by the moderate ~30-fold changes in K_M seen at different registry positions.

Other significant revisions:

1) Wu et al., (EMBO 2017) extensively characterized how the DNA substrate is handled during each cycle of repeat synthesis and suggested a more detailed catalytic cycle than what is proposed in Figure 1 here. It involved partial duplex melting before the synthesis reaches the template 5' end, allowing translocation to occur. It has also been shown that the kinetics of the addition of each nt within each telomeric repeat is not the same (Chen et al., 2018). So far the structures and kinetics have only been done with one single addition of dGTP in this work, which will be different for other nucleotides of the repeat. This point needs to be carefully addressed.

We wish to thank the reviewers for highlighting the complexity of the catalytic cycle, and template position dependence of incoming nucleotides. Further clarification about both phenomena have been added to the manuscript text and also below for reference. Additionally, Figure 1 in the manuscript has been carefully updated to better clarify and address the details of the catalytic cycle.

“This core catalytic cycle repeats six times, until a new telomeric repeat is added (Figure 1A, state C₆). All 18 telomerase states that are required to add one telomeric repeat are shown in Figure 1— figure supplement 3 for reference. Importantly, as the telomerase approaches the end of its template, the DNA:RNA duplex at the 5’ end begins to melt, enabling telomerase to either (1) translocate and anneal the RNA component to the newly extended telomeric repeat, thus allowing for additional repeat addition; or (2) dissociate from the telomeric DNA.”

“Our experiments were carried out specifically with a single dGTP insertion using a 4 nucleotide overhang RNA template. While telomerase has been shown to exhibit moderate base and position-specific effects, our results indicate that the telomerase catalytic core generally exhibits moderate base selection fidelity, similar to that of X-family polymerases involved in DNA repair (Chen et al., 2018; McCulloch and Kunkel, 2008).”

2) The authors identified critical residues for the catalytic activity and fidelity, revealing similarities and differences with other DNA polymerases. This said, while Tribolium TERT provides a good model system for studying TERT structure, it lacks the TEN domain and a large part of the IFD, which have been shown to be crucial for TERT activity and processivity in human and Tetrahymena. This major difference and whether the kinetics observations can be generalized to other telomerases warrants a discussion.

We carefully chose Tribolium castaneum TERT as a model TERT with full knowledge that it lacks both the TEN domain and a large part of the IFD, compared to hTERT. We agree and wish to thank the reviewers for suggesting that we explicitly acknowledge and discuss this important difference amongst TERTs. To address this, we have created a new table further entailing the differences between several different TERTs and added text discussing these crucial differences.

“Although TERTs have highly conserved active sites, there are significant changes in the domain architecture between human and tcTERT. These include tcTERT lacking the N-terminal (TEN) domain and missing a portion of the insertion in fingers domain (IFD) (Supplementary file 1—table 1B). These domains are essential for the activity of other telomerase homologs, and have been hypothesized to be particularly important for telomerase ratcheting during translocation (Steczkiewicz et al., 2011). Therefore, we kept our tcTERT kinetics within a single turnover (i.e. insertion) regime, and, wherever possible, complemented the kinetic results with human telomerase studies to characterize the catalytic cycle of telomerase.”

3) The Y717 steric gate is required for discriminating dNTPs from rNTPs, which is nicely shown in the human telomerase case. There is indeed a correlation between the number nucleotide in the repeat and the rate of incorporation. However, it is intriguing that the enzyme is still able to incorporate a couple of repeats with rATP. This suggests that in the human case the rATP in this position can be tolerated to some extent. Besides the sugar gate, could the base identity have some effects too?

We are grateful to the reviewers for commenting that base-identity could also play a role in ribonucleotide tolerance. We originally thought that the number of insertions per repeat was dominating this effect, but agree that base identity and position in the template could also influence ribonucleotide tolerance by telomerase. This is particularly interesting, as rATP is present at a much higher concentration than other ribonucleotides in the cell (Traut, 1994), so it would make sense that more rATPs would be inserted, and therefore need to be tolerated. These ideas have been included in the text.

“In the most extreme case of three rNTPs present per repeat, extension products are evident well into the second repeat, in contrast to the WT telomerase which had almost no insertion events (Figure 5E). We hypothesize that the rGTP insertion drastically inhibits WT telomerase because the first two insertions in the repeat are templated by rC. Therefore, the first event would need to be a rNTP insertion, followed by another rNTP insertion from a potentially unstable primer terminus. We are unable to decipher if inhibitory effects are due to the number of ribonucleotides per repeat, sequence-dependent inhibition, or a combination of both. In contrast to rGTP, telomerase is able to incorporate multiple repeats when rATP is present, albeit at a reduced efficiency compared to dNTPs (Figure 5E).”

4) The description of critical residues surrounding RNA as well as incoming nucleotide is often too vague. More modeling or description is needed. For instance, how does R194 relocation/move between different state?

Thank you to the reviewers for this comment. We welcome a chance to expand a bit more on our structural results, and have added more descriptions throughout that section, including how R194’s position and environment change throughout the catalytic cycle. Please see changes to the Results section.

5) Please provide details to those who are not familiar with T. casteneum telomerase such as the TERT and TR molecular weights and how they differ from human or mouse telomerase. Also the authors should elaborate more on the TR version for T. casteneum. We assume as readers that the authors could not co-crystalize with "tcTR" for similar reasons as the field is not able to crystalize human hTR + hTERT. Please provide some background on that (perhaps in the Introduction).

We thank the reviewers for the opportunity to further clarify the differences between TERT homologs. As the TR component of telomerase creates flexibility and heterogeneity in the structure, the reviewers are correct that any telomerase holoenzyme with a TR component is a poor substrate for crystallography, which is why we used a truncated version of the TR. To address this (and point 2 above), we’ve created a supplemental table (Supplementary file 1—table 1B) entailing the differences in domain architecture and molecular weight between several TERTs from different species, in addition to altering the introductory text:

“…third, using a truncated version of the T. castaneum telomerase RNA component (TR), we can readily obtain sufficient quantities of isolated, active tcTERT for characterization of the telomerase catalytic cycle by pre-steady-state kinetics and X-ray crystallography (Gillis et al., 2008; Nguyen et al., 2018). Although TERTs have highly conserved active sites, there are significant changes in the domain architecture between human and tcTERT. These include tcTERT lacking the Nterminal (TEN) domain and missing a portion of the insertion in fingers domain (IFD) (Supplementary file 1—table 1B). These domains are essential for the activity of other telomerase homologs, and have been hypothesized to be particularly important for telomerase ratcheting during translocation (Steczkiewicz et al., 2011). Therefore, we kept our tcTERT kinetics within a single turnover (i.e. insertion) regime, and, wherever possible, complemented the kinetic results with human telomerase studies to characterize the catalytic cycle of telomerase.”

6) It seems that the authors generated the RNA:DNA hybrid substrate prior to incubating with tcTERT. What was the reason for this? Could they incubate the RNA 16-mer with tcTERT to allow that complex to assemble and then add the 15-mer complimentary DNA substrate? Would they see the same results? Technically speaking the substrate for telomerase is the DNA (nucleotide or single stranded). The RNA is a part of the enzymatic complex.

Thank you for the feedback on the generation of our TERT:RNA:DNA complex. We agree that in a biological context, the RNA component of telomerase is assembled as part of the enzymatic complex before it binds to DNA. Hence, for the human telomerase experiments, we assembled the RNA component with telomerase prior to running any of our human telomerase reactions. In our structural studies with tcTERT, we preincubated the RNA and DNA prior to the addition of TERT because a homogenous sample is vital for crystal formation. We hypothesize that mixing TERT with the RNA component prior to adding the DNA could result in excess free DNA strands or a TERT:RNA complex that isn’t bound to the DNA, which could prevent crystal formation. Furthermore, when we compare the position of the RNA strand from our structure to that from a recent cryo-EM structure of telomerase holoenzyme (that was made by incubating TERT:RNA with the DNA strand, Jiang et al., 2018) the position of the RNA strand overlays well between the two structures within the active site of the enzyme (Author response image 2). Therefore, we do not predict that changing the order of assembly greatly impacts the structure of the TERT:RNA:DNA complexes that are formed over the course of days in a crystallization solution.

Author response image 2

Download asset Open asset

For our pre-steady-state kinetic regime, it is of utmost importance that the enzymatic complex is fully assembled prior to introducing the nucleotide triphosphates. This way, the rate limiting steps for catalysis are only the binding of the nucleotide and the subsequent enzymatic turnover; if we only incubated TERT with the RNA template, and then initiated the reaction by adding the DNA strand and the next incoming nucleotide, it is likely that at that point the rate limiting step would be the annealing of the two nucleic acid strands rather than nucleotide binding and subsequent insertion. Therefore, in these assays, we also needed to preincubate the duplex prior to starting the reaction.

7) Subsection “Product complex”. It makes sense that there are minimal rearrangements since it could be predicted that the majority of movement is in the RNA subunit of telomerase (which is missing in this model). However, a key question is to know how it stays on and translocates after a full hexameric repeat is added. The authors may want to review a recent paper (J. Biol. Chem., 294(30):11579-11588, 2019). This work provides a more macro look at the telomerase catalytic cycle that may provide some insights into the present studies.

Thank you for directing our attention to this recent publication; we agree that the macro look at the catalytic cycle is relevant to the present studies, and have made note of some of the key findings of this paper in our introduction of the catalytic cycle. As we see an inactivation of telomerase upon insertion of ribonucleotides, an outstanding question is whether the mechanism of inactivation is related to the catalysis-dependent inactivation observed in the Sayed et al. study. One possibility is that reactivation with iTAFs would increase translocation efficiency with noncanonical substrates. We do feel that these questions, although interesting, lie outside of the scope of the present manuscript.

“Importantly, as the telomerase approaches the end of its template, the DNA:RNA duplex at the 5’ end begins to melt, enabling telomerase to either (1) translocate and anneal the RNA component to the newly extended telomeric repeat, thus allowing for additional repeat addition; or (2) dissociate from the telomeric DNA. The number of times that a single telomerase enzyme traverses this catalytic cycle is tightly regulated. It was recently shown telomerase becomes inactive after two repeats, but can be reactivated by the recently discovered intracellular telomerase-activating factors (iTAFs) (Sayed et al., 2019).”

8) Please elaborate on the chemistry step vs nucleotide binding step.

We have elaborated on these two steps in context of the catalytic cycle for clarity:

“Next, the binary complex binds an incoming dNTP and samples for proper Watson-Crick base pairing to the RNA template (Figure 1A, state B₁). The transition between these two states represents the nucleotide binding step, measured as a dissociation constant (K_d). If the resulting ternary complex (TERT:DNA:dNTP) is in the proper orientation, TERT will catalyze the formation of a phosphodiester bond and extend the telomere by one nucleotide (Figure 1A, state C₁). The transition between these two states is the chemistry step, and its theoretical maximum rate with saturating nucleotide concentration is described as k_pol. Following insertion of the incoming nucleotide, telomerase will shift registry to align the active site with the next templating base (forming state A₂).”

9) Subsection “The steric gate of telomerase” paragraph three. Please include the details of the telomerase used. Was a recombinant telomerase with 3xFLAG tag and overexpressed hTR used? This is important as we have now seen that the tags used for telomerase play a role for in-vitro and in-vivo activity.

Yes, the telomerase used was a recombinant telomerase with 3xFLAG tag and overexpressed hTR (see below). For clarity on the construct used, more details of the methods were added to the Results section:

“In these assays, 1.5 telomeric repeats with the sequence TTAGGGTTAG were incubated with 50 µM of either all four dNTPs or all four rNTPs and purified 3xFLAG tagged human telomerase overexpressed with hTR.”

10) Figure 5C. If you generated a custom single-stranded substrate with dNTPs and rNTPs, would you even lose that first extension? Maybe an experiment like this will test the assumption that it "may inhibit the telomerase translocation step."

How pre-existing ribonucleotides in a telomere strand might affect even the first extension of telomerase is a particularly interesting question. This type of question is something we became interested in during prior studies with modified nucleotides inserted into telomeres (Fouquerel et al., 2016). In the case of 8oxoguanine or 8-oxodGTP, pre-existing 8-oxoG in the telomere strand increased telomerase activity by disrupting G-quadruplex structures that prevented telomerase binding, whereas 8-oxodGTP that was inserted by telomerase inhibited the activity of telomerase. This example highlights the complexity of characterizing the effect of inserted non-canonical nucleotides vs pre-existing modified nucleotides in an annealed oligo.

In response to this question, we refer the reviewers to a publication that examined the impact of ribonucleotides in the template for telomerase (Collins and Greider, 1995, EMBO). Briefly, telomerase primer extension assays were performed using primers containing various amounts of ribonucleotides present in the primer strand (see Figure 6 in the referenced work). As predicted by the reviewers, in some cases, placing ribonucleotides in the primer strand inhibited even the first extension of telomerase. In other cases, such as the oligonucleotide that only had three ribonucleotides present (sequence: d(G₃T₂G)₂G₃r(U₂G) ), telomerase extended the substrate with a reduced efficiency. We feel that the insights from these hybrid substrates better inform our interpretation of how ribonucleotides influence the mechanism of telomerase. Therefore, we added a reference to the work to better make our case that ribonucleotides inhibit telomerase translocation:

“This reduction was evident even with a single rNTP present in a telomeric repeat. Furthermore, previous studies have found telomeric substrates containing ribonucleotides can prevent or reduce extension of the first repeat depending on the number and position of ribonucleotides present in the DNA template (Collins and Greider, 1995).”

11) Subsection “The steric gate of telomerase” paragraph four. rGTP displayed the greatest inhibition. Is this because 3Gs are in the hexameric repeat or is this due to something else? Some discussion on this would be helpful.

We agree that rGTP presence alone exhibited the greatest inhibition out of any of the single ribonucleotides tested. We hypothesize that the inhibition by rGTP is caused by factors in the telomeric sequence. Because the first templating base is an rC in our experimental setup, the first insertion event will be rGTP. In cases where that is successful, the next base in the sequence is also an rC, requiring the extension from a potentially unstable primer terminus, followed by yet another rGTP insertion. Therefore, telomerase cannot increase telomere length much past the initial primer terminus, potentially limiting the binding and keeping it engaged to the telomere end (with only three nucleotides base pairing). With all this in mind, we do concede that unknown effects specific to guanine could also be occurring, but we cannot test these effects without altering the telomere and TR sequences, which would alter insertion efficiencies of telomerase. We do think this adds to the Discussion, and have expanded on this in the manuscript:

“In the most extreme case of three rNTPs present per repeat, extension products are evident well into the second repeat, in contrast to the WT telomerase which had almost no insertion events (Figure 5E). We hypothesize that the rGTP insertion drastically inhibits WT telomerase because the first two insertions in the repeat are templated by rC. Therefore, the first event would need to be a rNTP insertion, followed by another rNTP insertion from a potentially unstable primer terminus. We are unable to decipher if inhibitory effects are due to the number of ribonucleotides per repeat, sequence-dependent inhibition, or a combination of both. In contrast to rGTP, telomerase is able to incorporate multiple repeats when rATP is present, albeit at a reduced efficiency compared to dNTPs (Figure 5E).”

12) While all alterations resulted in reduction of telomere extension by telomerase, did any alterations tested enhance telomere extension (e.g. decreased pausing, improved processivity etc). This should be mentioned in the Discussion.

None of the alterations in this study enhanced telomerase extension and this is a mutation we are very interested in identifying in future studies. We have made a note emphasizing these results in the manuscript:

“Therefore, in order to prevent this telomeric disruption, the telomerase active site appears to have evolved a high degree of stringency towards noncanonical nucleotides, including both rNTPs and mismatched dNTPs. This stringency was evident by the reduced telomere elongation efficiency with every variant tested; other mutations could also be identified with this system that show increases in telomere elongation efficiency.”

13) Any evidence in the current series of experiment that the alterations of inserted ribonucleotides causes DNA damage or lack of shelterin protection. While this has been shown by others in cells using altered nucleotide insertion into telomeres, there are no cell-based studies in the present studies to confirm or progress much of the speculation in the Discussion since all experiments in the present studies use a somewhat artificial in vitro (test tube) approach. For example, do altered ribonucleotides persist in telomeres and is there any evidence that RER removes them? Also, what is the evidence that a single misinsertion every 10kb would prevent shelterin binding or disrupt G-quadruplex stability? Even with these concerns, the studies are important to help future studies confirm and extend these finding.

We would like to thank the reviewer for bringing up these points, and we agree that both the steady-state levels and the biological impacts of ribonucleotides and mismatches in telomere strands are pressing questions brought up by the current study. As such, we have more explicitly outlined the biological question that the present study brings to light. We are already establishing new techniques in our laboratory, including cell culture and modified telomere restriction fragment analysis to answer some of these questions, but they are as of yet unknown, and we believe outside of the scope of the current manuscript.

“While the downstream consequences of telomeric mismatches have not been studied in a biological context to our knowledge, they likely would disrupt G-quadruplex stability and inhibit shelterin protein binding, as both of these phenomena are dependent on DNA sequence (Figure 6B) (Burge, et al., 2006; de Lange, 2005).”

“…[T]elomerase inserts ~40 rNTPs, which represents selectivity comparable to DNA polymerase β and DNA polymerase δ (Brown and Suo, 2011; Cavanaugh, Beard and Wilson, 2010; McElhinny et al., 2010). However, it is unknown whether ribonucleotides persist in telomeres, their biological consequences, and if they are addressed with ribonucleotide excision repair (RER), similar to other genomic ribonucleotides (Sparks et al., 2012).”

Author details

1. Matthew A Schaich

   Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, United States

   Contribution

   Conceptualization, Data curation, Formal analysis, Investigation, Writing - original draft, Writing - review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-6771-5623

2. Samantha L Sanford

   Department of Environmental and Occupational Health, University of Pittsburgh Graduate School of Public Health, and UPMC Hillman Cancer Center, Pittsburgh, United States

   Contribution

   Data curation

   Competing interests

   No competing interests declared

3. Griffin A Welfer

   Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, United States

   Contribution

   Data curation

   Competing interests

   No competing interests declared

4. Samuel A Johnson

   Department of Environmental and Occupational Health, University of Pittsburgh Graduate School of Public Health, and UPMC Hillman Cancer Center, Pittsburgh, United States

   Contribution

   Data curation

   Competing interests

   No competing interests declared

5. Thu H Khoang

   Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, United States

   Contribution

   Data curation

   Competing interests

   No competing interests declared

6. Patricia L Opresko

   Department of Environmental and Occupational Health, University of Pittsburgh Graduate School of Public Health, and UPMC Hillman Cancer Center, Pittsburgh, United States

   Contribution

   Supervision, Writing - review and editing

   Competing interests

   No competing interests declared

7. Bret D Freudenthal

   1. Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, United States
   2. Department of Cancer Biology, University of Kansas Medical Center, Kansas City, United States

   Contribution

   Conceptualization, Supervision, Funding acquisition, Writing - original draft, Writing - review and editing

   For correspondence

   bfreudenthal@kumc.edu

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-1449-4710

• 2,406

  Page views

• 244

  Downloads

• 14

  Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.